Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment [1]

Hematology Journal

Volumn 5, Issue 5, 2004, Pages 451-452

  Fietz, Thomas ^a   Rieger, Kathrin ^a   Schmittel, Alexander ^a   Thiel, Eckhard ^a   Knauf, Wolfgang ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CD103 ANTIGEN; CD20 ANTIBODY; CLADRIBINE; CORTICOSTEROID; COTRIMOXAZOLE; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR; RITUXIMAB;

ANEMIA; BRONCHOSPASM; CASE REPORT; DRUG HYPERSENSITIVITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GENERAL CONDITION IMPROVEMENT; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; LETTER; PROTEIN EXPRESSION; RELAPSE; SPLENECTOMY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CLADRIBINE; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNIZATION, PASSIVE; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; RECURRENCE; REMISSION INDUCTION; SPLENECTOMY;

EID: 5444223561     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200373     Document Type: Letter

References (7)

1. Hoffman M, Auerbach L. Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine. Br J Haematol, 2000; 109: 900-901.
2. Hagberg H, Lundholm L. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol 2001; 115: 609-611.
3. Lauria F, Lenoci M, Annino L, Raspadori D, Marotta G, Bocchia M et al. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. Haematologica 2001; 86: 1046-1050.
4. Nieva J, Bethel K, Saven A. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 2003; 102: 810-813.
5. Thomas DA, O'Brien S, Buesco-Ramos C, Faderl S, Keating MJ, Giles FJ et al. Rituximab in relapsed of refractory hairy cell leukemia. Blood, 2003; 102: 3906-3911.
6. Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med 2001; 345: 241-247.
7. Kreitman RJ, Wilson WH, Robbins D, Margulies I, Stetler-Stevenson M, Waldmann TA et al. Responses in refractory hairy cell leukemia to a recombinant immunotoxin. Blood 1999; 94: 3340-3348.